IP : Oxford Nanopore Technologies and SeqOne partner to support interpretation of nanopore sequencing in clinical use -March 12, 2024 at 10:46 am EDT
11 Mar 2024 A new partnership will provide end-to-end solutions from sample to report for whole genome nanopore sequencing reads at scale in future clinical...
Source: marketscreener.com